Paper42092016
Opportunities for antenatal medical treatment of genetic conditions: the earlier, the better.
Bianchi DW. Pediatr Res, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Opportunities for antenatal medical treatment of genetic conditions: the earlier, the better. Papers, record 42092016. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42092016
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Opportunities for antenatal medical treatment of genetic conditions: the earlier, the better.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 42918831 | Correction: Opportunities for antenatal medical treatment of genetic conditions: the earlier, the better. | https://conductscience.org/library/papers/42918831 |
Source PubMed
References14
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30067923 | Sequencing of Circulating Cell-free DNA during Pregnancy. | N Engl J Med | 2018 | https://conductscience.org/library/papers/30067923 | PubMed |
| 2 | 31264685 | Quantitative MRI Analyses of Regional Brain Growth in Living Fetuses with Down Syndrome. | Cereb Cortex | 2020 | https://conductscience.org/library/papers/31264685 | PubMed |
| 3 | 37544351 | Embryonic statistical analyses reveal 2 growth phenotypes in mouse models of Down syndrome. | Am J Obstet Gynecol | 2024 | https://conductscience.org/library/papers/37544351 | PubMed |
| 4 | 27586445 | An Integrated Human/Murine Transcriptome and Pathway Approach To Identify Prenatal Treatments For Down Syndrome. | Sci Rep | 2016 | https://conductscience.org/library/papers/27586445 | PubMed |
| 5 | 39533854 | Analysis of genotype effects and inter-individual variability in iPSC-derived trisomy 21 neural progenitor cells. | Hum Mol Genet | 2025 | https://conductscience.org/library/papers/39533854 | PubMed |
| 6 | 29199020 | The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations. | Cell Syst | 2018 | https://conductscience.org/library/papers/29199020 | PubMed |
| 7 | 33098770 | Apigenin as a Candidate Prenatal Treatment for Trisomy 21: Effects in Human Amniocytes and the Ts1Cje Mouse Model. | Am J Hum Genet | 2020 | https://conductscience.org/library/papers/33098770 | PubMed |
| 8 | 39737640 | JAK inhibition decreases the autoimmune burden in Down syndrome. | Elife | 2024 | https://conductscience.org/library/papers/39737640 | PubMed |
| 9 | 36813963 | Autoimmunity in Down's syndrome via cytokines, CD4 T cells and CD11c+ B cells. | Nature | 2023 | https://conductscience.org/library/papers/36813963 | PubMed |
| 10 | 39794210 | Absolute quantification of cell-free DNA for prenatal genetics and oncology. | Trends Biotechnol | 2025 | https://conductscience.org/library/papers/39794210 | PubMed |
| 11 | 34268058 | A Review of Trikafta: Triple Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Therapy. | Cureus | 2021 | https://conductscience.org/library/papers/34268058 | PubMed |
| 12 | 40754574 | PRenatal mOdulator treatment to PrEvent CF complicaTions (PROTECT) workshop report. | J Cyst Fibros | 2025 | https://conductscience.org/library/papers/40754574 | PubMed |
| 13 | 39645477 | Outcomes of prenatal use of elexacaftor/tezacaftor/ivacaftor in carrier mothers to treat meconium ileus in fetuses with cystic fibrosis. | J Cyst Fibros | 2025 | https://conductscience.org/library/papers/39645477 | PubMed |
| 14 | 35710144 | Prospectively evaluating maternal and fetal outcomes in the era of CFTR modulators: the MAYFLOWERS observational clinical trial study design. | BMJ Open Respir Res | 2022 | https://conductscience.org/library/papers/35710144 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CFTR | 1080 | PubTator's text mining | https://conductscience.org/library/genes/1080 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42092016
GET https://conductscience.org/api/papers/v1/42092016/authors